Alnylam Pharmaceuticals Inc (ALNY)

238.00 -4.50 (-1.86%) USD  |  NASDAQ  |  Dec 27, 16:00
237.94 -0.06 (-0.03%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Gross Profit (Annual): 1.518B for Dec. 31, 2023

Gross Profit (Annual) Chart

View Gross Profit (Annual) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Gross Profit Definition

View Gross Profit Definition
Start Trial

Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.

Read full definition.

Gross Profit (Annual) Range, Past 5 Years

View Gross Profit (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (Annual) Benchmarks

View Gross Profit (Annual) Benchmarks
Start Trial
Pfizer Inc 33.54B
BridgeBio Pharma Inc 6.857M
Gilead Sciences Inc 20.62B
Sarepta Therapeutics Inc 1.093B
Regeneron Pharmaceuticals Inc 11.30B